TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the Phase 2 clinical trial Results to be presented at the ...
‘I don’t think I’d be enjoying this as much if it wasn’t for the human element,’ she admits ... Puerta began dreaming about setting up a new tech-driven business that could harness the superstar power ...
At the e4m D2C Revolution Summit 3.0, industry leaders shared insights on mastering digital marketing for D2C success ...